| Year |
Citation |
Score |
| 2023 |
Hioe CE, Liu X, Banin AN, Heindel DW, Klingler JR, Rao PG, Luo CC, Jiang X, Pandey S, Ordonez T, Barnette P, Totrov M, Zhu J, Na das A, Zolla-Pazner S, et al. Corrigendum: Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1. Frontiers in Immunology. 14: 1329069. PMID 38022586 DOI: 10.3389/fimmu.2023.1329069 |
0.353 |
|
| 2023 |
Hioe CE, Liu X, Banin AN, Heindel DW, Klingler J, Rao PG, Luo CC, Jiang X, Pandey S, Ordonez T, Barnette P, Totrov M, Zhu J, Nádas A, Zolla-Pazner S, et al. Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1. Frontiers in Immunology. 14: 1271686. PMID 37854587 DOI: 10.3389/fimmu.2023.1271686 |
0.409 |
|
| 2023 |
Heindel D, Acosta DF, Goff M, Jan M, Wang XH, Petrova M, Chan KW, Kong XP, Chen B, Mahal L, Bensing B, Hioe C. HIV-1 interaction with an O-glycan-specific bacterial lectin enhances virus infectivity and cell-to-cell viral transfer. Research Square. PMID 36824869 DOI: 10.21203/rs.3.rs-2596269/v1 |
0.493 |
|
| 2022 |
Hioe CE, Li G, Liu X, Tsahouridis O, He X, Funaki M, Klingler J, Tang AF, Feyznezhad R, Heindel DW, Wang XH, Spencer DA, Hu G, Satija N, Prévost J, et al. Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice. Plos Pathogens. 18: e1010183. PMID 34986207 DOI: 10.1371/journal.ppat.1010183 |
0.467 |
|
| 2021 |
Tang AF, Enyindah-Asonye G, Hioe CE. Immune Complex Vaccine Strategies to Combat HIV-1 and Other Infectious Diseases. Vaccines. 9. PMID 33540685 DOI: 10.3390/vaccines9020112 |
0.336 |
|
| 2020 |
Upadhyay C, Feyznezhad R, Cao L, Chan KW, Liu K, Yang W, Zhang H, Yolitz J, Arthos J, Nadas A, Kong XP, Zolla-Pazner S, Hioe CE. Signal peptide of HIV-1 envelope modulates glycosylation impacting exposure of V1V2 and other epitopes. Plos Pathogens. 16: e1009185. PMID 33370382 DOI: 10.1371/journal.ppat.1009185 |
0.368 |
|
| 2020 |
Weiss S, Klingler J, Hioe C, Amanat F, Baine I, Arinsburg S, Kojic EM, Stoever J, Liu STH, Jurczyszak D, Bermudez-Gonzalez M, Simon V, Krammer F, Zolla-Pazner S. A High Through-Put Assay For Circulating Antibodies Directed Against The S Protein Of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2). The Journal of Infectious Diseases. PMID 32860510 DOI: 10.1093/Infdis/Jiaa531 |
0.32 |
|
| 2019 |
Soare AY, Malik HS, Durham ND, Freeman TL, Alvarez R, Patel F, Satija N, Upadhyay C, Hioe CE, Chen BK, Swartz TH. P2X1 selective antagonists block HIV-1 infection through inhibition of envelope conformation-dependent fusion. Journal of Virology. PMID 31852781 DOI: 10.1128/Jvi.01622-19 |
0.603 |
|
| 2019 |
Jan M, Upadhyay C, Hioe CE. HIV-1 Envelope Glycan Composition as a Key Determinant of Efficient Virus Transmission via DC-SIGN and Resistance to Inhibitory Lectins. Iscience. 21: 413-427. PMID 31704652 DOI: 10.1016/J.Isci.2019.10.030 |
0.559 |
|
| 2018 |
Hioe CE, Kumar R, Upadhyay C, Jan M, Fox A, Itri V, Peachman KK, Rao M, Liu L, Lo NC, Tuen M, Jiang X, Kong XP, Zolla-Pazner S. Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex Vaccines. Frontiers in Immunology. 9: 2441. PMID 30416503 DOI: 10.3389/Fimmu.2018.02441 |
0.483 |
|
| 2018 |
Jan M, Upadhyay C, Alcami Pertejo J, Hioe CE, Arora SK. Heterogeneity in glycan composition on the surface of HIV-1 envelope determines virus sensitivity to lectins. Plos One. 13: e0194498. PMID 29579062 DOI: 10.1371/Journal.Pone.0194498 |
0.526 |
|
| 2018 |
Upadhyay C, Feyznezhad R, Yang W, Zhang H, Zolla-Pazner S, Hioe CE. Alterations of HIV-1 envelope phenotype and antibody-mediated neutralization by signal peptide mutations. Plos Pathogens. 14: e1006812. PMID 29370305 DOI: 10.1371/Journal.Ppat.1006812 |
0.553 |
|
| 2018 |
Balasubramanian P, Williams C, Shapiro MB, Sinangil F, Higgins K, Nádas A, Totrov M, Kong XP, Fiore-Gartland AJ, Haigwood NL, Zolla-Pazner S, Hioe CE. Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials. Scientific Reports. 8: 542. PMID 29323175 DOI: 10.1038/S41598-017-18863-0 |
0.422 |
|
| 2017 |
Jan M, Upadhyay C, Sharma A, Hioe CE, Arora SK. Manα1-2Man binding anti-HIV lectins enhance the exposure of V2i and V3 crown neutralization epitopes on the V1V2 and V3 hypervariable loops of HIV-1 Envelope. Aids Research and Human Retroviruses. PMID 28322582 DOI: 10.1089/Aid.2016.0262 |
0.542 |
|
| 2017 |
Balasubramanian P, Kumar R, Williams C, Itri V, Wang S, Lu S, Hessell AJ, Haigwood NL, Sinangil F, Higgins KW, Liu L, Li L, Nyambi P, Gorny MK, Totrov M, ... ... Hioe CE, et al. Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination. Vaccine. PMID 28185743 DOI: 10.1016/J.Vaccine.2016.11.107 |
0.531 |
|
| 2016 |
Deng J, Mitsuki YY, Shen G, Ray J, Cicala C, Arthos J, Dustin ML, Hioe CE. HIV envelope gp120 alters T-cell receptor mobilization in the immunological synapse of uninfected CD4 T cells and augments the T cell activation. Journal of Virology. PMID 27630246 DOI: 10.1128/Jvi.01532-16 |
0.708 |
|
| 2016 |
Zolla-Pazner S, Powell R, Yahyaei S, Williams C, Jiang X, Li W, Lu S, Wang S, Upadhyay C, Hioe CE, Totrov M, Kong X. RATIONALLY-DESIGNED VACCINES TARGETING THE V2 REGION OF HIV-1 gp120 INDUCE A FOCUSED, CROSS CLADE-REACTIVE, BIOLOGICALLY FUNCTIONAL ANTIBODY RESPONSE. Journal of Virology. PMID 27630234 DOI: 10.1128/Jvi.01403-16 |
0.575 |
|
| 2016 |
Mitsuki YY, Tuen M, Hioe CE. Differential effects of HIV transmission from monocyte-derived dendritic cells vs. monocytes to IL-17+CD4+ T cells. Journal of Leukocyte Biology. PMID 27531931 DOI: 10.1189/Jlb.4A0516-216R |
0.663 |
|
| 2016 |
Kumar R, Williams C, Itri V, Wang S, Lu S, Hessell A, Higgins K, Liu L, Haigwood N, Sinangil F, Gorny M, Totrov M, Kong X, Nadas A, Zolla-Pazner S, ... Hioe C, et al. P-C16 Differential Induction of Anti-V3 Crown Antibodies with Cradle and Ladle-Binding Modes in Response to HIV-1 Envelope Vaccination Journal of Acquired Immune Deficiency Syndromes. 71: 84. DOI: 10.1097/01.Qai.0000479635.49430.16 |
0.447 |
|
| 2015 |
Shen G, Upadhyay C, Zhang J, Pan R, Zolla-Pazner S, Kong XP, Hioe CE. Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies. Plos One. 10: e0141233. PMID 26491873 DOI: 10.1371/Journal.Pone.0141233 |
0.488 |
|
| 2015 |
Kumar R, Pan R, Upadhyay C, Mayr L, Cohen S, Wang XH, Balasubramanian P, Nádas A, Seaman MS, Zolla-Pazner S, Gorny MK, Kong XP, Hioe CE. Functional and structural characterization of human V3-specific monoclonal antibody 2424 with neutralizing activity against HIV-1 JRFL. Journal of Virology. PMID 26109728 DOI: 10.1128/Jvi.01280-15 |
0.487 |
|
| 2014 |
Poles J, Alvarez Y, Hioe CE. Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection. Aids Research and Human Retroviruses. 30: 1027-40. PMID 25354023 DOI: 10.1089/Aid.2014.0233 |
0.734 |
|
| 2014 |
Weiden MD, Hoshino S, Levy DN, Li Y, Kumar R, Burke SA, Dawson R, Hioe CE, Borkowsky W, Rom WN, Hoshino Y. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits HIV-1 replication in human alveolar macrophages. Plos One. 9: e108476. PMID 25272020 DOI: 10.1371/Journal.Pone.0108476 |
0.594 |
|
| 2014 |
Upadhyay C, Mayr LM, Zhang J, Kumar R, Gorny MK, Nádas A, Zolla-Pazner S, Hioe CE. Distinct mechanisms regulate exposure of neutralizing epitopes in the V2 and V3 loops of HIV-1 envelope. Journal of Virology. 88: 12853-65. PMID 25165106 DOI: 10.1128/Jvi.02125-14 |
0.531 |
|
| 2014 |
Cardozo T, Wang S, Jiang X, Kong XP, Hioe C, Krachmarov C. Vaccine focusing to cross-subtype HIV-1 gp120 variable loop epitopes. Vaccine. 32: 4916-24. PMID 25045827 DOI: 10.1016/J.Vaccine.2014.07.026 |
0.511 |
|
| 2014 |
Shen G, Upadhyay C, Zhang J, Pan R, Itri V, Zolla-Pazner S, Kong X, Hioe C. P-D10 Rationally Targeted Mutations to Stabilize the Flexible V2 loop Augment Neutralization of Different HIV-1 Isolates by V1V2 Monoclonal Antibodies Jaids Journal of Acquired Immune Deficiency Syndromes. 67: 91. DOI: 10.1097/01.Qai.0000456199.33185.16 |
0.447 |
|
| 2014 |
Upadhyay C, Zhang J, Kumar R, Gorny MK, Nadas A, Zolla-Pazner S, Hioe CE, Mayr L. G-103 Masking of the epitopes in the V2 and V3 loops of the HIV-1 envelope are modulated by different mechanisms Jaids Journal of Acquired Immune Deficiency Syndromes. 67: 68. DOI: 10.1097/01.Qai.0000456176.75558.D4 |
0.469 |
|
| 2013 |
Kumar R, Tuen M, Liu J, Nàdas A, Pan R, Kong X, Hioe CE. Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccines. Vaccine. 31: 5413-21. PMID 24051158 DOI: 10.1016/J.Vaccine.2013.09.010 |
0.504 |
|
| 2013 |
Alvarez Y, Tuen M, Shen G, Nawaz F, Arthos J, Wolff MJ, Poles MA, Hioe CE. Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands. Journal of Virology. 87: 10843-54. PMID 23903844 DOI: 10.1128/Jvi.01838-13 |
0.773 |
|
| 2013 |
Kumar R, Tuen M, Hioe C. ST109 Antigenic specificity and neutralizing activity of antibody responses elicited by different gp120/mAb immune complex vaccines Jaids Journal of Acquired Immune Deficiency Syndromes. 62: S68. DOI: 10.1097/01.Qai.0000429271.36210.4F |
0.343 |
|
| 2012 |
Yu X, Gilbert PB, Hioe CE, Zolla-Pazner S, Self SG. Statistical approaches to analyzing HIV-1 neutralizing antibody assay data. Statistics in Biopharmaceutical Research. 4: 1-13. PMID 24660049 DOI: 10.1080/19466315.2011.633860 |
0.341 |
|
| 2012 |
Kumar R, Visciano ML, Li H, Hioe C. Targeting a Neutralizing Epitope of HIV Envelope Gp120 by Immune Complex Vaccine. Journal of Aids & Clinical Research. PMID 22891160 DOI: 10.4172/2155-6113.S8-002 |
0.49 |
|
| 2012 |
Prins KC, Vasiliver-Shamis G, Cammer M, Depoil D, Dustin ML, Hioe CE. Imaging of HIV-1 envelope-induced virological synapse and signaling on synthetic lipid bilayers. Journal of Visualized Experiments : Jove. PMID 22433250 DOI: 10.3791/3757 |
0.833 |
|
| 2012 |
Alvarez Y, Tuen M, Nàdas A, Hioe CE. In vitro restoration of Th17 response during HIV infection with an antiretroviral drug and Th17 differentiation cytokines. Aids Research and Human Retroviruses. 28: 823-34. PMID 22011036 DOI: 10.1089/Aid.2011.0184 |
0.744 |
|
| 2012 |
Chiu Y, Jiang X, Kumar R, Hioe C, Zolla-Pazner S, Kong X. Skin tattooing as an effective tool for delivering DNA and protein vaccine immunogens Retrovirology. 9: 338. DOI: 10.1186/1742-4690-9-S2-P338 |
0.329 |
|
| 2011 |
van Montfort T, Eggink D, Boot M, Tuen M, Hioe CE, Berkhout B, Sanders RW. HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation. Journal of Immunology (Baltimore, Md. : 1950). 187: 4676-85. PMID 21957147 DOI: 10.4049/Jimmunol.1101876 |
0.608 |
|
| 2011 |
Kumar R, Tuen M, Li H, Tse DB, Hioe CE. Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation. Vaccine. 29: 9064-74. PMID 21945958 DOI: 10.1186/1742-4690-9-S2-P292 |
0.488 |
|
| 2011 |
Hioe CE, Tuen M, Vasiliver-Shamis G, Alvarez Y, Prins KC, Banerjee S, Nádas A, Cho MW, Dustin ML, Kachlany SC. HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA). Plos One. 6: e23202. PMID 21850260 DOI: 10.1097/01.Qai.0000413802.72027.88 |
0.807 |
|
| 2011 |
Agarwal A, Hioe CE, Swetnam J, Zolla-Pazner S, Cardozo T. Quantitative assessment of masking of neutralization epitopes in HIV-1. Vaccine. 29: 6736-41. PMID 21216319 DOI: 10.1016/J.Vaccine.2010.12.052 |
0.529 |
|
| 2010 |
Vasiliver-Shamis G, Dustin ML, Hioe CE. HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse. Viruses. 2: 1239-60. PMID 20890395 DOI: 10.3390/V2051239 |
0.816 |
|
| 2010 |
Hioe CE, Wrin T, Seaman MS, Yu X, Wood B, Self S, Williams C, Gorny MK, Zolla-Pazner S. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes. Plos One. 5: e10254. PMID 20421997 DOI: 10.1371/Journal.Pone.0010254 |
0.553 |
|
| 2010 |
Kachlany SC, Schwartz AB, Balashova NV, Hioe CE, Tuen M, Le A, Kaur M, Mei Y, Rao J. Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells. Leukemia Research. 34: 777-85. PMID 19747730 DOI: 10.1016/J.Leukres.2009.08.022 |
0.349 |
|
| 2009 |
Hioe CE, Visciano ML, Kumar R, Liu J, Mack EA, Simon RE, Levy DN, Tuen M. The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120. Vaccine. 28: 352-60. PMID 19879224 DOI: 10.1016/J.Vaccine.2009.10.040 |
0.477 |
|
| 2009 |
Vasiliver-Shamis G, Cho MW, Hioe CE, Dustin ML. Human immunodeficiency virus type 1 envelope gp120-induced partial T-cell receptor signaling creates an F-actin-depleted zone in the virological synapse. Journal of Virology. 83: 11341-55. PMID 19710135 DOI: 10.1128/Jvi.01440-09 |
0.835 |
|
| 2009 |
Li H, Xu CF, Blais S, Wan Q, Zhang HT, Landry SJ, Hioe CE. Proximal glycans outside of the epitopes regulate the presentation of HIV-1 envelope gp120 helper epitopes. Journal of Immunology (Baltimore, Md. : 1950). 182: 6369-78. PMID 19414790 DOI: 10.4049/Jimmunol.0804287 |
0.579 |
|
| 2009 |
Sachdev DD, Zerhouni-Layachi B, Ortigoza M, Profy AT, Tuen M, Hioe CE, Klotman ME. The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes. Journal of Acquired Immune Deficiency Syndromes (1999). 51: 125-9. PMID 19349871 DOI: 10.1097/Qai.0B013E31819F9E31 |
0.567 |
|
| 2009 |
Hioe C, Visciano M, Kumar R, Liu J, Tuen M. P05-03. The use of immune complexes to enhance antibody responses against neutralizing epitopes on HIV envelope Retrovirology. 6: 79. DOI: 10.1186/1742-4690-6-S3-P79 |
0.501 |
|
| 2009 |
Zolla-Pazner S, Kong X, Cardozo T, Hioe C, Cohen S, Jiang X, Gorny MK, Totrov M, Pinter A, Krachmarov C, Seaman MS, Wang S, Lu S. P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope Retrovirology. 6: P37. DOI: 10.1186/1742-4690-6-S3-P37 |
0.383 |
|
| 2009 |
Vasiliver-Shamis G, Cho MW, Dustin ML, Hioe CE. P07-03. HIV gp120 interaction with CD4+ T cells induces local intracellular signaling and creates an F-actin depleted zone in the virological synapse Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P101 |
0.789 |
|
| 2009 |
Vasiliver-Shamis G, Cho M, Dustin ML, Hioe CE. 119 HIV-1 envelope gp120 induces a stop signal and virological synapse formation in non-infected CD4+ T cells Jaids Journal of Acquired Immune Deficiency Syndromes. 51: 1. DOI: 10.1097/01.Qai.0000351076.74461.96 |
0.834 |
|
| 2008 |
Visciano ML, Tuen M, Chen PD, Hioe CE. Antibodies to the CD4-binding site of HIV-1 gp120 suppress gp120-specific CD4 T cell response while enhancing antibody response. Infectious Agents and Cancer. 3: 11. PMID 18638381 DOI: 10.1186/1750-9378-3-11 |
0.587 |
|
| 2008 |
Vasiliver-Shamis G, Tuen M, Wu TW, Starr T, Cameron TO, Thomson R, Kaur G, Liu J, Visciano ML, Li H, Kumar R, Ansari R, Han DP, Cho MW, Dustin ML, ... Hioe CE, et al. Human immunodeficiency virus type 1 envelope gp120 induces a stop signal and virological synapse formation in noninfected CD4+ T cells. Journal of Virology. 82: 9445-57. PMID 18632854 DOI: 10.1128/Jvi.00835-08 |
0.838 |
|
| 2008 |
Li H, Chien PC, Tuen M, Visciano ML, Cohen S, Blais S, Xu CF, Zhang HT, Hioe CE. Identification of an N-linked glycosylation in the C4 region of HIV-1 envelope gp120 that is critical for recognition of neighboring CD4 T cell epitopes. Journal of Immunology (Baltimore, Md. : 1950). 180: 4011-21. PMID 18322210 DOI: 10.4049/Jimmunol.180.6.4011 |
0.545 |
|
| 2008 |
Visciano ML, Tuen M, Gorny MK, Hioe CE. In vivo alteration of humoral responses to HIV-1 envelope glycoprotein gp120 by antibodies to the CD4-binding site of gp120. Virology. 372: 409-20. PMID 18054978 DOI: 10.1016/J.Virol.2007.10.044 |
0.481 |
|
| 2007 |
Kaur G, Tuen M, Virland D, Cohen S, Mehra NK, Münz C, Abdelwahab S, Garzino-Demo A, Hioe CE. Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection. Virology. 369: 214-25. PMID 17765942 DOI: 10.1016/J.Virol.2007.07.031 |
0.693 |
|
| 2006 |
Williams JG, Tomer KB, Hioe CE, Zolla-Pazner S, Norris PJ. The antigenic determinants on HIV p24 for CD4+ T cell inhibiting antibodies as determined by limited proteolysis, chemical modification, and mass spectrometry. Journal of the American Society For Mass Spectrometry. 17: 1560-9. PMID 16875837 DOI: 10.1016/J.Jasms.2006.06.011 |
0.51 |
|
| 2006 |
Visciano M, Tuen M, Robinson J, Gorny M, Hioe C. Role of anti-CD4-binding site antibodies in modulating gp120-specific CD4 T cell and antibody responses. Retrovirology. 3: 1-2. DOI: 10.1186/1742-4690-3-S1-S60 |
0.484 |
|
| 2006 |
Li H, Tuen M, Cohen S, Visciano ML, Hioe C. Effect of site-specific de-glycosylation on HIV gp120-specific CD4 T cell responses Retrovirology. 3. DOI: 10.1186/1742-4690-3-S1-S34 |
0.665 |
|
| 2006 |
Hioe C, Kaur G, Cohen S, Tuen M, Virland D, Abdelwahab S, Garzino-Demo A. Effect of HIV on production of anti-viral factors by HIV-specific CD4+ T cells Retrovirology. 3. DOI: 10.1186/1742-4690-3-S1-P25 |
0.679 |
|
| 2005 |
Tuen M, Visciano ML, Chien PC, Cohen S, Chen PD, Robinson J, He Y, Pinter A, Gorny MK, Hioe CE. Characterization of antibodies that inhibit HIV gp120 antigen processing and presentation. European Journal of Immunology. 35: 2541-51. PMID 16106369 DOI: 10.1002/Eji.200425859 |
0.479 |
|
| 2004 |
Chien PC, Cohen S, Tuen M, Arthos J, Chen PD, Patel S, Hioe CE. Human immunodeficiency virus type 1 evades T-helper responses by exploiting antibodies that suppress antigen processing. Journal of Virology. 78: 7645-52. PMID 15220439 DOI: 10.1128/Jvi.78.14.7645-7652.2004 |
0.634 |
|
| 2004 |
Chien PC, Chen D, Chen PD, Tuen M, Cohen S, Migueles SA, Connors M, Rosenberg E, Malhotra U, Gonzalez C, Hioe CE. HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation. The Journal of Infectious Diseases. 189: 852-61. PMID 14976603 DOI: 10.1086/380133 |
0.625 |
|
| 2003 |
Cohen S, Tuen M, Hioe CE. Propagation of CD4+ T cells specific for HIV type 1 envelope gp120 from chronically HIV type 1-infected subjects. Aids Research and Human Retroviruses. 19: 793-806. PMID 14585210 DOI: 10.1089/088922203769232593 |
0.699 |
|
| 2002 |
Chien PC, Cohen S, Kleeberger C, Giorgi J, Phair J, Zolla-Pazner S, Hioe CE. High levels of antibodies to the CD4 binding domain of human immunodeficiency virus type 1 glycoprotein 120 are associated with faster disease progression. The Journal of Infectious Diseases. 186: 205-13. PMID 12134256 DOI: 10.1086/341297 |
0.562 |
|
| 2001 |
Hioe CE, Tuen M, Chien P.C. J, Jones G, Ratto-Kim S, Norris PJ, Moretto WJ, Nixon DF, Gorny MK, Zolla-Pazner S. Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120 Journal of Virology. 75: 10950-10957. PMID 11602735 DOI: 10.1128/Jvi.75.22.10950-10957.2001 |
0.575 |
|
| 2001 |
Hioe CE, Chien PC, Lu C, Springer TA, Wang XH, Bandres J, Tuen M. LFA-1 expression on target cells promotes human immunodeficiency virus type 1 infection and transmission. Journal of Virology. 75: 1077-82. PMID 11134324 DOI: 10.1128/Jvi.75.2.1077-1082.2001 |
0.651 |
|
| 2000 |
Hioe CE, Jones GJ, Rees AD, Ratto-Kim S, Birx D, Münz C, Gorny MK, Tuen M, Zolla-Pazner S. Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120 Aids Research and Human Retroviruses. 16: 893-905. PMID 10875615 DOI: 10.1089/08892220050042837 |
0.658 |
|
| 1999 |
Hioe CE, Hildreth JEK, Zolla-Pazner S. Enhanced HIV type 1 neutralization by human anti-glycoprotein 120 monoclonal antibodies in the presence of monoclonal antibodies to lymphocyte function-associated molecule 1 Aids Research and Human Retroviruses. 15: 523-531. PMID 10221529 DOI: 10.1089/088922299311042 |
0.6 |
|
| 1998 |
Gorny MK, Mascola JR, Israel ZR, VanCott TC, Williams C, Balfe P, Hioe C, Brodine S, Burda S, Zolla-Pazner S. A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades Aids Research and Human Retroviruses. 14: 213-221. PMID 9491911 DOI: 10.1089/Aid.1998.14.213 |
0.511 |
|
| 1997 |
Hioe CE, Xu S, Chigurupati P, Burda S, Williams C, Gorny MK, Zolla-Pazner S. Neutralization of HIV-1 primary isolates by polyclonal and monoclonal human antibodies. International Immunology. 9: 1281-90. PMID 9310831 DOI: 10.1093/Intimm/9.9.1281 |
0.528 |
|
| 1997 |
Hioe C, Burda S, Chigurupati P, Xu S, Zolla-Pazner S. Resting cell neutralization assay for HIV-1 primary isolates. Methods (San Diego, Calif.). 12: 300-5. PMID 9245610 DOI: 10.1006/Meth.1997.0483 |
0.609 |
|
| 1997 |
Zolla-Pazner S, Alving C, Belshe R, Berman P, Burda S, Chigurupati P, Clements ML, Duliege AM, Excler JL, Hioe C, Kahn J, McElrath MJ, Sharpe S, Sinangil F, Steimer K, et al. Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines. The Journal of Infectious Diseases. 175: 764-74. PMID 9086128 DOI: 10.1086/513969 |
0.452 |
|
| 1997 |
Nixon DF, Hioe C, Chen PD, Bian Z, Kuebler P, Li ML, Qiu H, Li XM, Singh M, Richardson J, McGee P, Zamb T, Koff W, Wang CY, O'Hagan D. Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine. 14: 1523-30. PMID 9014294 DOI: 10.1016/S0264-410X(96)00099-0 |
0.36 |
|
| 1996 |
Allsopp CEM, Plebanski M, Gilbert S, Sinden RE, Harris S, Frankel G, Dougan G, Hioe C, Nixon D, Paoletti E, Layton G, Hill AVS. Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. European Journal of Immunology. 26: 1951-1959. PMID 8765044 DOI: 10.1002/Eji.1830260841 |
0.362 |
|
| Show low-probability matches. |